Invention Grant
- Patent Title: Concentrated, inhalable ciprofloxacin formulation
-
Application No.: US15299284Application Date: 2016-10-20
-
Publication No.: US10420765B2Publication Date: 2019-09-24
- Inventor: David C. Cipolla , James Blanchard
- Applicant: ARADIGM CORPORATION
- Applicant Address: US CA Hayward
- Assignee: ARADIGM CORPORATION
- Current Assignee: ARADIGM CORPORATION
- Current Assignee Address: US CA Hayward
- Agency: Bozicevic, Field & Francis LLP
- Agent Karl Bozicevic
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K9/00 ; A61K9/127 ; A61K9/12 ; A61K45/06 ; A61K47/22 ; A61K9/50
Abstract:
A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
Public/Granted literature
- US20170035753A1 CONCENTRATED, INHALABLE CIPROFLOXACIN FORMULATION Public/Granted day:2017-02-09
Information query
IPC分类:
